Postgraduate Course

Postgraduate Course

There have been tremendous advances in the science of hepatology and its impact on the management of patients with liver disease. This course will introduce new key concepts in the genetic and molecular basis of common liver diseases including nonalcoholic steatohepatitis (NASH), viral hepatitis, hepatobiliary malignancies and cholestatic liver diseases, built around a framework of clinical cases and expert lectures with session “wrap-ups” by moderators. In addition, a unique session will focus for the first time on the multidisciplinary approach to caring for patients with advanced liver disease, incorporating the perspectives of non-hepatologist experts in palliative care, allied subspecialties and team management. This course will engage attendees in the excitement and astonishing growth in the discipline of hepatology, and prepare them to meet the growing challenges of caring for patients with liver disease.

Goals and Objectives:

• Understand recent advances in the genetics and molecular biology of acute and chronic liver diseases and hepatobiliary malignancies;
• Appreciate the challenges and new opportunities in diagnosis and management of liver disease.
• Integrate the expertise of non-hepatology specialists in order to optimize quality and teamwork in managing patients with advanced liver disease.

Presentation Title	Presenter
Primer on Modern Genetics	Konstantinos Lazaridis, MD
"Omics" of the 21st Century	Geoffrey W. McCaughan, MD, PhD
Genetics of Heritable Biliary Diseases	Laura N. Bull, PhD
Pediatric Cholestasis	Jorge A. Bezerra, MD
Assessment of Genetic Risk of Liver Disease	Frank Lammert, MD
Hemochromatosis, Hepatology's Biggest Genetic Disease	Paul C. Adams, MD
"What I Just Learned" - Expert Wrap-up and Perspective	William F. Balistreri, MD
Cryptogenic Cirrhosis and NASH: Criteria of Diagnosis (Case Discussion)	Stephen H. Caldwell, MD
NASH, a Severe Hepatic Disease?	Vlad Ratziu, MD
Liver, Muscle, and Fat in Insulin Resistance - Targets for Therapy	Derek Leroith, MD, PhD
Evolving Concepts in Lipotoxicity and Dietary Fat	Kenneth Cusi, MD
Impact of NAFLD on Cardiovascular Disease	Giulio Marchesini, MD
"What I Just Learned" - Expert Wrap-up and Perspective	Arun J. Sanyal, MD
Patient with HBV and Resistance to Antiviral Therapy(s) (Case Discussion)	Mark S. Sulkowski, MD
Modern Endpoints for HBV Treatment	Ching-Lung Lai, MD
The Haunting Spectre of Viral Resistance in HBV	Stephen Locarnini, MD, PhD
HCV Model Systems: Pathogenesis and Future Therapies	T Jake Liang, MD
“What I Just Learned” - Expert Wrap-up and Perspective	Norah Terrault, MD
Fat and Fibrogenesis - Mechanisms and Significance	Frank A. Anania, MD
HCV, HIV and Molecular Mechanisms of Fibrogenesis	Meena B. Bansal, MD
New Diagnostic Tools in Assessment of Liver Injury, Fibrosis, Steatosis and Function	Robert P. Myers, MD
Antifibrotic and Hepatoprotectant Therapies - Hot Prospects and Challenges to Clinical Testing	Rebecca Wells, MD
Controversy: Is Liver Biopsy Still Necessary for Injury and Fibrosis Assessment? (Pro)	Pierre Bedossa, MD, PhD
Controversy: Is Liver Biopsy Still Necessary for Injury and Fibrosis Assessment? (Con)	K Rajender Reddy, MD
Hepatitis B (Case Discussion)	Jack R. Wands, MD
HCC Prophylaxis and Surveillance - Prospects and Evidence	Massimo Colombo, MD
Controversies and Conflicts in Diagnosis and Management of Cholangiocarcinoma	Julie Heimbach, MD
Molecular Pathogenesis of HCC	Josep M. Llovet, MD
“What I Just Learned” - Expert Wrap-up and Perspective	Adrian M. Di Bisceglie, MD
Critical Care in Patients with Liver Disease	Julia Wendon, MbChB, FRCP
Infectious Disease in Advanced Liver Disease	Shirish Huprikar, MD
Renal Disease Complicating Advanced Liver Disease	Warren Kupin, MD
Palliative Care in the Management of Patients with Liver Disease	Diane E. Meier, MD